HomeTagsNovo Nordisk A/S

Tag: Novo Nordisk A/S

Economy

Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, Health Department agency says

January 9, 2025

Economy

FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions

December 24, 2024

Economy

FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea, expanding use in U.S.

December 20, 2024

Economy

Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal

December 19, 2024

Economy

Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly

December 14, 2024

Economy

Eli Lilly’s Zepbound causes greater weight loss than Novo Nordisk’s Wegovy in head-to-head trial

December 7, 2024

Economy

Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says

December 7, 2024

Economy

Amgen says obesity drug caused up to 20% weight loss after a year, but shares drop 10%

November 26, 2024

Economy

Amgen stock falls as analysts mull over weight loss drug’s bone density data

November 13, 2024

Economy

Novo Nordisk’s Ozempic and Wegovy now available in the U.S. after shortages, FDA says

October 31, 2024

1...345 6 Page 4 of 6

Latest News

Aussie teen star misses out in Wimbledon qualifying bid

June 26, 2025

Salzburg vs Real Madrid LIVE streaming info: Where to watch FIFA Club World Cup 2025 match? Predicted lineups

June 26, 2025

Shane Baz Addresses His December 2017 FanGraphs Scouting Report

June 26, 2025

Over 18.9 lakh cos were active in India at May-end, shows official data

June 26, 2025

Here’s who to see this summer if you missed out on Glastonbury Festival

June 26, 2025

England names Archer in squad for second Test against India

June 26, 2025